|
CNS Role in Prescribing and Managing SGLT-2 Inhibitors and GLP-1 Therapy for DMI
| Description |
|
This 1-hour webinar will discuss how the CNS can utilize pharmaceutical guidelines to prescribe and manage GLP1 therapy and SGLT2 inhibitors to treat Type 2 Diabetes Mellitus and secondarily help patients with the problem of obesity.
|
|
